Linagliptin (BI-1356)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Linagliptin (BI-1356), covering 2012-10-26 to 2012-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study [Phase 3]